Journal of Cellular Biochemistry

Cover image for Journal of Cellular Biochemistry

Supplement: Cancer chemopreventive agents: drug development status and future prospects

1995

Volume 59, Issue S22

Pages fmi–fmi, 1–259

  1. Masthead

    1. Top of page
    2. Masthead
    3. Articles
    1. Masthead (page fmi)

      Article first published online: 19 FEB 2004 | DOI: 10.1002/jcb.240590801

  2. Articles

    1. Top of page
    2. Masthead
    3. Articles
    1. Retinoids and chemoprevention: Clinical and basic studies (pages 1–10)

      Scott M. Lippman, Richard A. Heyman, Jonathan M. Kurie, Steven E. Benner and Waun Ki Hong

      Article first published online: 19 FEB 2004 | DOI: 10.1002/jcb.240590802

    2. Controlled clinical trials with fenretinide in breast cancer, basal cell carcinoma and oral leukoplakia (pages 11–17)

      Giuseppe De Palo, Umberto Veronesi, Ettore Marubini, Tiziana Camerini, Fausto Chiesa, Maurizio Nava, Franca Formelli, Marcella Del Vecchio, Alberto Costa, Patrizia Boracchi and Luigi Mariani

      Article first published online: 19 FEB 2004 | DOI: 10.1002/jcb.240590803

    3. Do NSAIDs exert their colon cancer chemoprevention activities through the inhibition of mucosal prostaglandin synthetase? (pages 18–23)

      David S. Alberts, Lee Hixson, Dennis Ahnen, Cheryl Bogert, Janine Einspahr, Nancy Paranka, Klaus Brendel, Paul H. Gross, Rifat Pamukcu and Randall W. Burt

      Article first published online: 19 FEB 2004 | DOI: 10.1002/jcb.240590804

    4. Chemopreventive properties and mechanisms of N-acetylcysteine. The experimental background (pages 33–41)

      Silvio De Flora, Carmelo F. Cesarone, Roumen M. Balansky, Adriana Albini, Francesco D'Agostini, Carlo Bennicelli, Maria Bagnasco, Anna Camoirano, Leonardo Scatolini, Alessandra Rovida and Alberto Izzotti

      Article first published online: 19 FEB 2004 | DOI: 10.1002/jcb.240590806

    5. Tamoxifen's role in chemoprevention of breast cancer: An update (pages 42–50)

      Susan G. Nayfield

      Article first published online: 19 FEB 2004 | DOI: 10.1002/jcb.240590807

    6. Hormonally induced differentiation: A novel approach to breast cancer prevention (pages 58–64)

      José Russo and Irma H. Russo

      Article first published online: 19 FEB 2004 | DOI: 10.1002/jcb.240590809

    7. Calcium and the prevention of colon cancer (pages 65–73)

      Martin Lipkin and Harold Newmark

      Article first published online: 19 FEB 2004 | DOI: 10.1002/jcb.240590810

    8. Calcium—cell cycle regulator, differetiator, killer, chemopreventor, and maybe, tumor promoter (pages 74–91)

      James F. Whitfield, Ranjana P. Bird, Balu R. Chakravarthy, Richard J. Isaacs and Paul Morley

      Article first published online: 19 FEB 2004 | DOI: 10.1002/jcb.240590811

    9. Chemoprevention of cancer by organoselenium compounds (pages 92–100)

      Karam El-Bayoumy, Pramod Upadhyaya, Young-Heum Chae, Ock-Soon Sohn, Chinthalapally V. Rao, Emerich Fiala and Bandaru S. Reddy

      Article first published online: 19 FEB 2004 | DOI: 10.1002/jcb.240590812

    10. Oltipraz: Clinical opportunities for cancer chemoprevention (pages 101–107)

      Thomas W. Kensler and Kathy J. Helzlsouer

      Article first published online: 19 FEB 2004 | DOI: 10.1002/jcb.240590813

    11. Effects of oltipraz and related chemoprevention compounds on gene expression in rat liver (pages 108–116)

      Leigh Anderson, Vernon K. Steele, Gary J. Kelloff and Sheela Sharma

      Article first published online: 19 FEB 2004 | DOI: 10.1002/jcb.240590814

    12. Oltipraz, a novel inhibitor of human immunodeficiency virus type 1 (HIV-1) replication (pages 117–125)

      Hans J. Prochaska, Surendra J. Chavan, Penny Baron and Bruce Polsky

      Article first published online: 19 FEB 2004 | DOI: 10.1002/jcb.240590815

    13. Development of difluoromethylornithine as a chemoprevention agent for the management of colon cancer (pages 126–131)

      Frank L. Meyskens Jr. and Eugene W. Gerner

      Article first published online: 19 FEB 2004 | DOI: 10.1002/jcb.240590816

    14. Ornithine decarboxylase as a target for chemoprevention (pages 132–138)

      Anthony E. Pegg, Lisa M. Shantz and Catherine S. Coleman

      Article first published online: 19 FEB 2004 | DOI: 10.1002/jcb.240590817

    15. Prevention and therapy of mammary cancer by monoterpenes (pages 139–144)

      Dr. Michael N. Gould

      Article first published online: 19 FEB 2004 | DOI: 10.1002/jcb.240590818

    16. Development of inhibitors of protein farnesylation as potential chemotherapeutic agents (pages 145–150)

      Nancy E. Kohl, Michael W. Conner, Jackson B. Gibbs, Samuel L. Graham, George D. Hartman and Allen Oliff

      Article first published online: 19 FEB 2004 | DOI: 10.1002/jcb.240590819

    17. Probing the molecular program of apoptosis by cancer chemopreventive agents (pages 151–161)

      Laszlo Fésüs, Zsuzsa Szondy and Ivan Uray

      Article first published online: 19 FEB 2004 | DOI: 10.1002/jcb.240590820

    18. Polyphenols as cancer chemopreventive agents (pages 169–180)

      Gary D. Stoner and Hasan Mukhtar

      Article first published online: 19 FEB 2004 | DOI: 10.1002/jcb.240590822

    19. Rationale for the use of genistein-containing soy matrices in chemoprevention trials for breast and prostate cancer (pages 181–187)

      Stephen Barnes, T. Greg Peterson and Lori Coward

      Article first published online: 19 FEB 2004 | DOI: 10.1002/jcb.240590823

    20. Chemoprevention by isothiocyanates (pages 195–209)

      Stephen S. Hecht

      Article first published online: 19 FEB 2004 | DOI: 10.1002/jcb.240590825

    21. Cancer prevention with dehydroepiandrosterone and non-androgenic structural analogs (pages 210–217)

      Arthur G. Schwartz and Laura L. Pashko

      Article first published online: 19 FEB 2004 | DOI: 10.1002/jcb.240590826

    22. β-Carotene and cancer chemoprevention (pages 226–230)

      Julie E. Buring and Charles H. Hennekens

      Article first published online: 19 FEB 2004 | DOI: 10.1002/jcb.240590828

    23. Lutein, lycopene, and their oxidative metabolites in chemoprevention of cancer (pages 236–246)

      Frederick Khachik, Gary R. Beecher and J. Cecil Smith Jr.

      Article first published online: 19 FEB 2004 | DOI: 10.1002/jcb.240590830

    24. Butyrate and phenylacetate as differentiating agents: Practical problems and opportunities (pages 247–253)

      Harold L. Newmark and Charles W. Young

      Article first published online: 19 FEB 2004 | DOI: 10.1002/jcb.240590831

    25. Fostering chemopreventive agent development: How to proceed? (pages 254–259)

      James L. Mulshine

      Article first published online: 19 FEB 2004 | DOI: 10.1002/jcb.240590832

SEARCH

SEARCH BY CITATION